KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Other Non-Current Assets: 2018-2025

Historic Other Non-Current Assets for Castle Biosciences (CSTL) over the last 7 years, with Sep 2025 value amounting to $1.3 million.

  • Castle Biosciences' Other Non-Current Assets fell 29.98% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year decrease of 29.98%. This contributed to the annual value of $1.2 million for FY2024, which is 14.72% down from last year.
  • According to the latest figures from Q3 2025, Castle Biosciences' Other Non-Current Assets is $1.3 million, which was up 3.30% from $1.2 million recorded in Q2 2025.
  • In the past 5 years, Castle Biosciences' Other Non-Current Assets registered a high of $2.7 million during Q1 2022, and its lowest value of $792,000 during Q1 2023.
  • Its 3-year average for Other Non-Current Assets is $1.5 million, with a median of $1.3 million in 2025.
  • In the last 5 years, Castle Biosciences' Other Non-Current Assets soared by 719.60% in 2021 and then tumbled by 70.66% in 2023.
  • Over the past 5 years, Castle Biosciences' Other Non-Current Assets (Quarterly) stood at $1.7 million in 2021, then plummeted by 35.28% to $1.1 million in 2022, then climbed by 29.73% to $1.4 million in 2023, then fell by 14.72% to $1.2 million in 2024, then dropped by 29.98% to $1.3 million in 2025.
  • Its Other Non-Current Assets was $1.3 million in Q3 2025, compared to $1.2 million in Q2 2025 and $1.3 million in Q1 2025.